Physician profile
Eman Imran
NPI 1952115065
$478.36
in general payments reported to CMS, 2019-2025
10 companies · $478 in 2025
The $478 reported for 2025 was more than what a typical Medical provider received nationally (typical 2025 total: $213).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2025: $478.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $478.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $478.36 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals Lp | $164.41 | 2025 | Airsupra |
| Globus Medical, INC. | $73.30 | 2025 | Senza |
| Bsn Medical INC | $72.38 | 2025 | |
| Hologic Sales and Service, LLC | $38.32 | 2025 | Aptima, Thinprep 2000 Processor |
| Inspire Medical Systems, INC. | $37.04 | 2025 | Inspire |
| Novo Nordisk INC | $20.77 | 2025 | Wegovy |
| Saluda Medical Americas, INC. | $20.57 | 2025 | Evoke |
| Pfizer INC. | $19.49 | 2025 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $16.71 | 2025 | Xifaxan |
| Abbvie INC. | $15.37 | 2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Eman Imran listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.